These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6429306)

  • 21. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
    Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
    Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the selective lysis and purification of Trypanosoma cruzi.
    Nogueira N; Bianco C; Cohn Z
    J Exp Med; 1975 Jul; 142(1):224-9. PubMed ID: 807672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human trypanosome infection and the presence of intradomicile Rhodnius pallescens in the western border of the Panama Canal, Panama.
    Calzada JE; Pineda V; Montalvo E; Alvarez D; Santamaría AM; Samudio F; Bayard V; Cáceres L; Saldaña A
    Am J Trop Med Hyg; 2006 May; 74(5):762-5. PubMed ID: 16687677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-independent, natural resistance of birds to Trypanosoma cruzi infection.
    Kierszenbaum F; Gottlieb CA; Budzko DB
    J Parasitol; 1981 Oct; 67(5):656-60. PubMed ID: 6795329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation between Trypanosoma cruzi and T. rangeli by their different complement sensitivity.
    Schottelius J
    Tropenmed Parasitol; 1982 Sep; 33(3):147-50. PubMed ID: 6814023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanolytic activity and antibodies to metacyclic trypomastigotes of Trypanosoma cruzi in non-Chagasic human sera.
    Yoshida N; Araguth MF
    Parasite Immunol; 1987 May; 9(3):389-93. PubMed ID: 3299227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality profiles of Rhodnius prolixus (Heteroptera: Reduviidae), vector of Chagas disease.
    Chaves LF; Hernandez MJ; Revilla TA; Rodríguez DJ; Rabinovich JE
    Acta Trop; 2004 Oct; 92(2):119-25. PubMed ID: 15350863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanosoma cruzi - vector-vertebrate hosts interactions.
    Garcia ES
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():211-2. PubMed ID: 10677718
    [No Abstract]   [Full Text] [Related]  

  • 29. Extracts of airborne grain dusts activate alternative and classical complement pathways.
    Olenchock SA; Mull JC; Major PC
    Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles.
    Doherty M; Whicher JT; Dieppe PA
    Ann Rheum Dis; 1983 Jun; 42(3):285-91. PubMed ID: 6407405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
    Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
    Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement.
    Tomlinson S; Pontes de Carvalho LC; Vandekerckhove F; Nussenzweig V
    J Immunol; 1994 Oct; 153(7):3141-7. PubMed ID: 8089492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission dynamics of Trypanosoma cruzi determined by low-stringency single primer polymerase chain reaction and southern blot analyses in four indigenous communities of the Sierra Nevada de Santa Marta, Colombia.
    Rodríguez IB; Botero A; Mejía-Jaramillo AM; Marquez EJ; Ortiz S; Solari A; Triana-Chávez O
    Am J Trop Med Hyg; 2009 Sep; 81(3):396-403. PubMed ID: 19706903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of trypomastigote forms of Trypanosoma cruzi into activators of alternative complement pathway by immune IgG fragments.
    Kipnis TL; Krettli AU; Dias da Silva W
    Scand J Immunol; 1985 Aug; 22(2):217-26. PubMed ID: 3898353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
    Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
    J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi.
    Cestari Idos S; Evans-Osses I; Freitas JC; Inal JM; Ramirez MI
    J Infect Dis; 2008 Nov; 198(9):1276-83. PubMed ID: 18781865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic development of Trypanosoma cruzi in Rhodnius prolixus: role of decapitation and ecdysone therapy.
    Cortez MG; Gonzalez MS; Cabral MM; Garcia ES; Azambuja P
    Parasitol Res; 2002 Jul; 88(7):697-703. PubMed ID: 12107464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of multiclonal infections of Trypanosoma cruzi from naturally infected triatomine bugs and from experimentally infected mice by direct plating on a sensitive solid medium.
    Yeo M; Lewis MD; Carrasco HJ; Acosta N; Llewellyn M; da Silva Valente SA; de Costa Valente V; de Arias AR; Miles MA
    Int J Parasitol; 2007 Jan; 37(1):111-20. PubMed ID: 17052720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteins anchored via glycosylphosphatidylinositol and solubilizing phospholipases in Trypanosoma cruzi.
    de Almeida ML; Heise N
    Biol Res; 1993; 26(1-2):285-312. PubMed ID: 7670541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.